Fountzilas C, Bajor DL, Mukherjee S, Saltzman J, et al. Phase Ib/II study of Cetuximab Plus Pembrolizumab in Patients with Advanced RAS wild-type Colorectal Cancer. Clin Cancer Res 2021 Oct 13. pii: 1078-0432.CCR-21-1650.
PMID: 34645646